ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...

Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...

Pediatric patients with moderate to severe hidradenitits suppurativa may now receive secukinumab following new FDA approval for those aged 12 and up.

Is the impact of the war in the Middle East on Irish consumers becoming any clearer? The situation is still best described as ...

Oil markets are being shaken once again globally by geopolitical strains in the Middle East. The mounting tension between the United States, Israel and Iran has cast serious doubts over the security ...

Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a ...

Johnson & Johnson (JNJ) on Wednesday announced that the U.S. Food and Drug Administration (FDA) approved Icotyde, a once-daily pill developed with Protagonist Therapeutics (PTGX), as a treatment for ...

US FDA approves Novartis Cosentyx for paediatric patients aged 12+ with moderate to severe hidradenitis suppurativa: Basel Monday, March 16, 2026, 14:00 Hrs [IST] Novartis announc ...

Pakistan is navigating a dilemma between fulfilling strict fiscal requirements of its $7-billion IMF programme and protecting citizens from record-breaking inflation during Ramadan ...

Find all the best things to do in Pittsburgh this weekend, from NatureFest to the Pittsburgh Fringe Festival to the Japanese Film Festival.

The wines are kosher under the supervision of Badatz HaEdah HaCharedit and are sold at a recommended price of 55 NIS per bottle. The launch marks a significant expansion in the company’s activity into ...